SEC Filings

SEC Filings

Filing date	Description	Form	View
Sep 15, 2020	Report of unscheduled material events or corporate event	8-K	View HTML 0001104659-20-105074.pdf 0001104659-20-105074.rtf 0001104659-20-105074.xls
Aug 20, 2020	Statement of changes in beneficial ownership of securities	4	View HTML 0001790300-20-000001.pdf 0001790300-20-000001.rtf 0001790300-20-000001.xls
Aug 20, 2020	An amendment to a SC 13D filing	SC 13D/A	View HTML 0000919574-20-005466.pdf 0000919574-20-005466.rtf 0000919574-20-005466.xls
Aug 20, 2020	Statement of changes in beneficial ownership of securities	4	View HTML 0000919574-20-005470.pdf 0000919574-20-005470.rtf 0000919574-20-005470.xls
Aug 13, 2020	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-20-010555.pdf 0001558370-20-010555.rtf 0001558370-20-010555.xls
Aug 13, 2020	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001558370-20-010559.pdf 0001558370-20-010559.rtf 0001558370-20-010559.xls EX-101.INS - EX-101.INS
Jul 21, 2020	Statement of changes in beneficial ownership of securities	4	View HTML 0000919574-20-004650.pdf 0000919574-20-004650.rtf 0000919574-20-004650.xls
Jun 26, 2020	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-20-007814.pdf 0001558370-20-007814.rtf 0001558370-20-007814.xls
May 14, 2020	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-20-006609.pdf 0001558370-20-006609.rtf 0001558370-20-006609.xls
May 14, 2020	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001558370-20-006627.pdf 0001558370-20-006627.rtf 0001558370-20-006627.xls EX-101.INS - EX-101.INS

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE